Maybe the biggest reason is the "perception" that revenue was pushed from April 1st to September 30th. Back in January, OWCP stated they "should" complete effacy tests in Q2. Some people erroneously instantly translated that to mean sales start April 1st & yelled it from the roof top. Now, due to many good reasons, they've said they expect product readiness in Q3 so people assume worst case scenario of September 30. The reality is there have been NO Setback's to product development.
(0)
(0)
OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links